docetaxel
Showing 51 - 75 of 1,353
Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)
Completed
- Prostate Cancer
- docetaxel
- sorafenib tosylate
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 16, 2022
Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)
Suspended
- Triple Negative Breast Cancer
- Anthracycline-refractory TNBC
- Docetaxel
- +2 more
-
Houston, TexasHouston Methodist Cancer Center
Mar 28, 2022
Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)
Recruiting
- Recurrent Non-small Cell Lung Cancer
- Cisplatin
- +7 more
-
Changchun, Jilin, China
- +2 more
May 3, 2022
Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)
Completed
- Prostate Cancer
- Docetaxel
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 12, 2022
Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)
Active, not recruiting
- Prostate Cancer
- +2 more
- PROSTVAC-V
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022
Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)
Suspended
- Prostate Cancer
- 177Lu-PSMA-617
- Docetaxel
-
Vancouver, British Columbia, Canada
- +3 more
Jun 13, 2022
Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))
Active, not recruiting
- Prostatic Neoplasm
- Docetaxel
- Androgen-Deprivation Therapy (ADT)
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)
Recruiting
- Metastatic Castrate Resistant Prostate Cancer
- Docetaxel
- Radium 223
-
Boston, Massachusetts
- +3 more
Feb 22, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Docetaxel, Nivolumab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Docetaxel
- Nivolumab
-
Shanghai, Shanghai, ChinaGuo Ye
Jan 27, 2022
NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)
Terminated
- Non-small Cell Lung Cancer
- Pevonedistat
- Docetaxel
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 16, 2021
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Cancer of Head and Neck Trial in Lyon (Docetaxel, Cisplatin, Fluoro Uracil)
Recruiting
- Cancer of Head and Neck
- Docetaxel
- +2 more
-
Lyon, FranceCentre Leon Berard
Mar 10, 2022
Nsclc Trial in Beijing (HL-085, Docetaxel)
Terminated
- Nsclc
- HL-085
- Docetaxel
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Science
Nov 29, 2021
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Metastatic Non-Small Lung Cell Cancer
- +4 more
- Docetaxel
- +2 more
-
Atlanta, GeorgiaWinship Cancer Institute of Emory University
Oct 19, 2022
Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and
Completed
- Prostate Cancer
- Docetaxel
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022
HER2-positive Breast Cancer, Adjuvant Therapy Trial in Hangzhou (Paclitaxel, Trastuzumab, Docetaxel)
Recruiting
- HER2-positive Breast Cancer
- Adjuvant Therapy
- Paclitaxel
- +2 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 26, 2021
Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)
Recruiting
- Non Small Cell Lung Cancer
- quaratusugene ozeplasmid
- +3 more
-
Tampa, Florida
- +2 more
Sep 12, 2022
Neutropenia, Breast Cancer Trial in United States (Eflapegrastim, Docetaxel, Cyclophosphamide)
Recruiting
- Neutropenia
- Breast Cancer
- Eflapegrastim
- +2 more
-
Tucson, Arizona
- +7 more
Nov 4, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
- (no location specified)
May 5, 2022